MDT

78.23

3.34% -2.70

Handel nachbörslich: 78.22 -0.01 -0.01%

Medtronic Plc (MDT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$80.93

Offen:

$81.11

24-Stunden-Volumen:

9.86M

Relative Volume:

0.98

Marktkapitalisierung:

$100.14B

Einnahmen:

$36.36B

Nettoeinkommen (Verlust:

$4.84B

KGV:

21.02

EPS:

3.7212

Netto-Cashflow:

$5.43B

1W Leistung:

-2.98%

1M Leistung:

+5.99%

6M Leistung:

-18.56%

1J Leistung:

-10.26%

1-Tages-Spanne:

$78.14

$81.20

1-Wochen-Bereich:

$78.14

$82.48

52-Wochen-Spanne:

$73.31

$106.33

Medtronic Plc Stock (MDT) Company Profile

Firmenname

Medtronic Plc

Sektor

Healthcare (1095)

Branche

Medical Devices (140)

Telefon

01135314381700

Adresse

BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY

Mitarbeiter

95,000

Twitter

@Medtronic

Nächster Verdiensttermin

2026-08-18

Neueste SEC-Einreichungen

MDT's Discussions on Twitter

Compare MDT vs ABT, SYK, BSX, EW

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MDT Medtronic Plc	78.23	103.66B	36.36B	4.84B	5.43B	3.7212
ABT Abbott Laboratories	90.74	163.94B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	314.84	127.55B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	42.68	65.74B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	90.46	52.27B	6.30B	1.07B	1.09B	1.8406

Medtronic Plc Stock (MDT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-02-13	Fortgesetzt	Barclays	Overweight
2026-02-09	Hochstufung	Needham	Hold → Buy
2026-02-03	Fortgesetzt	Citigroup	Buy
2026-01-30	Fortgesetzt	Wells Fargo	Overweight
2026-01-06	Hochstufung	William Blair	Mkt Perform → Outperform
2025-11-19	Hochstufung	Goldman	Sell → Neutral
2025-06-30	Hochstufung	Wolfe Research	Underperform → Peer Perform
2025-06-16	Eingeleitet	Leerink Partners	Outperform
2025-03-04	Hochstufung	Citigroup	Neutral → Buy
2024-10-10	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2024-08-21	Bestätigt	Oppenheimer	Perform
2024-08-15	Hochstufung	UBS	Sell → Neutral
2024-08-14	Herabstufung	Stifel	Buy → Hold
2024-05-30	Eingeleitet	Goldman	Sell
2023-07-19	Eingeleitet	Robert W. Baird	Neutral
2023-06-30	Eingeleitet	CL King	Buy
2023-05-30	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-04-24	Hochstufung	Wells Fargo	Equal Weight → Overweight
2023-03-29	Herabstufung	UBS	Buy → Sell
2023-01-09	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2022-11-23	Herabstufung	Citigroup	Buy → Neutral
2022-11-23	Herabstufung	Oppenheimer	Outperform → Perform
2022-11-16	Herabstufung	Deutsche Bank	Buy → Hold
2022-10-18	Eingeleitet	Barclays	Equal Weight
2022-10-13	Eingeleitet	Mizuho	Buy
2022-10-12	Eingeleitet	Jefferies	Hold
2022-08-24	Herabstufung	Raymond James	Outperform → Mkt Perform
2022-07-06	Eingeleitet	Wolfe Research	Underperform
2022-06-01	Herabstufung	Atlantic Equities	Overweight → Neutral
2022-05-27	Herabstufung	Needham	Buy → Hold
2022-04-13	Herabstufung	Truist	Buy → Hold
2022-03-02	Fortgesetzt	BofA Securities	Buy
2022-01-10	Herabstufung	BTIG Research	Buy → Neutral
2022-01-07	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-01-04	Herabstufung	Piper Sandler	Overweight → Neutral
2021-12-17	Herabstufung	JP Morgan	Overweight → Neutral
2021-12-16	Herabstufung	Wells Fargo	Overweight → Equal Weight
2021-12-10	Eingeleitet	RBC Capital Mkts	Outperform
2021-06-10	Fortgesetzt	Cowen	Outperform
2021-05-25	Eingeleitet	Barclays	Equal Weight
2021-04-15	Eingeleitet	Atlantic Equities	Overweight
2020-12-15	Hochstufung	Goldman	Sell → Neutral
2020-12-15	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-10-08	Hochstufung	Bernstein	Mkt Perform → Outperform
2020-10-08	Hochstufung	Stifel	Hold → Buy
2020-09-11	Eingeleitet	Wolfe Research	Peer Perform
2020-05-14	Herabstufung	DZ Bank	Buy → Hold
2020-03-30	Herabstufung	Needham	Strong Buy → Buy
2020-03-25	Hochstufung	DZ Bank	Hold → Buy
2020-03-05	Eingeleitet	Citigroup	Buy
2020-02-13	Eingeleitet	Goldman	Sell
2020-01-08	Eingeleitet	SunTrust	Buy
2020-01-02	Hochstufung	Guggenheim	Neutral → Buy
2019-06-05	Hochstufung	Wells Fargo	Market Perform → Outperform
2019-02-04	Bestätigt	Needham	Strong Buy
2019-01-03	Eingeleitet	Deutsche Bank	Buy
2019-01-02	Herabstufung	Citigroup	Buy → Neutral
2018-12-19	Hochstufung	JP Morgan	Neutral → Overweight
2018-11-28	Eingeleitet	UBS	Buy
2018-10-16	Eingeleitet	Barclays	Overweight
2018-08-27	Bestätigt	Argus	Buy

Alle ansehen

Medtronic Plc Aktie (MDT) Neueste Nachrichten

Jun 30, 2026

Medtronic Data Breach Exposes Personal Information: Murphy Law Firm Investigates Legal Claims - GlobeNewswire Inc.

Jun 30, 2026

Is Medtronic PLC (MDT) a Bargain After 3.3% Drop? GF Value Says Undervalued - GuruFocus

Jun 30, 2026

Medtronic PLC Stock (MDT) Closed Down by 3.30% on Jun 30: Key Drivers Unveiled - TradingKey

Jun 30, 2026

Medtronic reports solid Q4 earnings, shares steady ahead August update - AD HOC NEWS

Jun 30, 2026

Jun 29, 2026

Is Medtronic plc (MDT) A Good Stock To Buy Now? - Insider Monkey

Jun 29, 2026

Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic - MedTech Dive

Jun 29, 2026

Medtronic plc refines diabetes portfolio, shares reflect mixed analyst stance - AD HOC NEWS

Jun 29, 2026

MiniMed widens board as it builds out as an independent diabetes tech company - Stock Titan

Jun 29, 2026

Medtronic clears spin-off milestone, diabetes IPO plans keep the stock in focus - AD HOC NEWS

Jun 29, 2026

Here is Why Medtronic (MDT) is One of the Best Long Term Stocks to Buy According to Hedge Funds - Yahoo Finance

Jun 29, 2026

Jun 28, 2026

Medtronic: Coming Back, But Not Yet Ready For Greatness (NYSE:MDT) - Seeking Alpha

Jun 28, 2026

Is Medtronic (MDT) A Bargain After Renal Denervation Optimism And Strong Revenue Growth? - simplywall.st

Jun 28, 2026

Medtronic plc tariff impact clarified, shares stay anchored in S&P 500 context - Ad-hoc-news.de

Jun 28, 2026

Price to book forward of Medtronic plc. – NYSE:MDT - TradingView

Jun 28, 2026

Jun 27, 2026